HIV

Globally, dolutegravir is expected to be a part of treatment for approximately 15 million people living with HIV by 2021.

Significant morbidity and mortality are associated with an aging population due to cardiovascular disease, which is very common in HIV-infected persons.

Fostemsavir is indicated for adults with drug resistant HIV.

Dolutegravir tablets are intended to treat pediatric patients at least 4 weeks old and at least 6 pounds who have never been treated for HIV or who have been treated, but not with an integrase strand transferase inhibitor class drug, according to the press release.

New research on the structure of HIV has revealed a promising novel drug target for treating HIV infection.

Today, we’re celebrating the clinical pharmacy specialist team at the William J. Holloway Community Program in Delaware.

The 2 most common, recommended, and simplified treatments for HCV are glecaprevir/pibrentasvir (Mavyret) and sofosbuvir/velpatasvir (Epclusa).

The widely available anti-parasitic drug ivermectin is capable of killing COVID-19 within 48 hours in a cell culture, according to a new study.

What would you recommend for these patients?

A study of the second HIV patient to undergo successful stem cell transplantation from donors with an HIV-resistant gene found that there was no active viral infection in the patient’s blood 30 months after they stopped antiretroviral therapy.

The findings highlight the critical role played by excess visceral adiposity in the progression of fibrosis among HIV-infected patients with nonalcoholic fatty liver disease, according to the study authors.

In addition, the new legislation calls for more intervention from local and state health officers, allowing them to recommend options ranging from testing to counseling. This includes the ability to mandate treatment for an individual determined to be placing others at risk.

Scientists at the Gladstone Institutes have cataloged host proteins that physically bind to HIV proteins, which identify human proteins that the virus can use to infect cells and spread.

The bill is intended to "prevent a health insurance carrier from requiring a covered person to undergo step therapy or to receive prior authorization before receiving HIV infection prevention drugs."

The Undectectable = Untransmittable (U=U) campaign started in early 2016 and has been sharing the message to dismantle the stigma surrounding HIV ever since. More than 970 community partners from 101 countries have come together to clear up the confusion about the science behind U=U.

Potential discrimination is at issue in a case against the insurer for mandating use of a specialty pharmacy.

Research conducted by the National Institute of Minority Health and Health Disparities has found that less than 1 in 4 adolescent men who have sex with men (AMSM) ever get tested for HIV.

Common medications containing polyvalent cations should be separated to prevent decreased absorption of the HIV therapy.

The scope of HIV/AIDS treatment in America has changed immensely in recent years across the pharmacy landscape. Roosevelt University's College of Pharmacy (RUCOP) is helping to highlight this shift in its updated HIV/AIDS care and training program.

Top news from across the health care landscape.

Users will be able to export reports and collect metrics with the new interactive platform, as well as readily access the information on mobile platforms.

The mechanism behind HIV resistance affects the ability of integrase strand transfer inhibitors to bind and block the HIV enzyme integrase.

Top news of the day from across the health care landscape.

Robust data show the efficacy of tenofovir disoproxil fumarate with emtricitabine for pre-exposure prophylaxis in all priority populations with a risk for HIV.

Top news of the day from across the health care landscape.